PERHAPS A GIFT VOUCHER FOR MUM?: MOTHER'S DAY

Close Notification

Your cart does not contain any items

Mesoporous silica and gold-based nanodevices

new controlled delivery platforms for biomedical applications

Gema Vivo Llorca

$84.95   $72.58

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Self
18 March 2024
"Tiny Tech for Targeted Treatment: Mesoporous Silica and Gold Nanoparticles in BiomedicineImagine microscopic delivery vehicles carrying potent drugs directly to diseased cells, minimizing harm to healthy tissue. This exciting field is explored in ""Mesoporous Silica and Gold-Based Nanodevices: New Controlled Delivery Platforms for Biomedical Applications."" This doctoral thesis delves into the design and application of innovative nanomaterials for targeted drug delivery, particularly in the fight against breast cancer.

The thesis focuses on two promising nanomaterials: mesoporous silica and gold nanoparticles. Mesoporous silica boasts a sponge-like structure, ideal for encapsulating drugs and releasing them in a controlled manner. Gold nanoparticles, on the other hand, offer unique properties like biocompatibility and the ability to attach targeting molecules, guiding the nanodevice to specific cells.

By combining these materials, researchers create ""hybrid nanodevices"" with remarkable abilities. One example involves a nanodevice loaded with two anti-cancer drugs and equipped with a ""molecular gate"" that unlocks only upon reaching cancer cells. This targeted approach promises to overcome drug resistance and reduce side effects.

Another exciting application involves a pH-responsive nanodevice designed for gene editing. This tiny carrier delivers the CRISPR/Cas9 gene editing machinery directly to diseased cells, offering a potential future for gene therapy."

By:  
Imprint:   Self
Dimensions:   Height: 229mm,  Width: 152mm,  Spine: 9mm
Weight:   231g
ISBN:   9798869261472
Pages:   166
Publication Date:  
Audience:   General/trade ,  ELT Advanced
Format:   Paperback
Publisher's Status:   Active

See Also